Home / News

A Number of IVD Companies Reached Cooperation (Oct, 2020)

2020/11/2 17:41:24 Views£º594

Dian Diagnostics reached a cooperation with Huzhou Municipal Health Commission to jointly improve the regional COVID-19 detection capabilities

 

On October 28th , Hangzhou Dian Medical Testing Center Co., Ltd., a subsidiary of Dian Diagnostics, signed the "Cooperation Agreement on Nucleic Acid Detection of COVID-19" with  Huzhou Municipal Health Commission.

 

According to the agreement, Huzhou Municipal Health Commission will support and guide Dian Diagnostics to establish a nucleic acid testing experimental center in Huzhou as a strategic reserve, and will reach a testing capacity of 100,000 copies/day in a special period to meet local large-scale nucleic acid testing needs .The testing center is expected to be put into use before 2021, and has the ability to meet the requirements of fever patients, general outpatient and emergency patients, inpatients and accompanying staff, and "willing to do all the inspection" groups to issue test reports within the nationally prescribed time limit.

ͼ1.jpg

 


Edan partners with Tencent to digitally reshape the management of chronic cardiovascular and cerebrovascular diseases

 

On October 27th ,Edan Instruments, Inc. and Tencent Medical Code formally signed a strategic cooperation agreement.

 

In this strategic agreement cooperation, the two parties will create a more systematic, professional and comprehensive innovative management model for cardiovascular and cerebrovascular diseases.In addition, both parties will jointly build an integrated data platform for patients with cardiovascular and cerebrovascular diseases in the construction of ECG big data, relying on scientific rigorous and industry-recognized cardiovascular risk prediction models to provide patients with cardiovascular risk self-examination and online consultation services to create health management for the whole disease cycle.

ͼ2.jpg

 


Fosun Long March and Siemens Healthineers sign a strategic cooperation agreement

 

On October 20th , Shanghai Fosun Long March Medical Science Co., Ltd.

and Siemens Healthineers formally signed a strategic cooperation agreement in Shanghai. Fosun Long March will be the first batch of Chinese partners of Siemens Medical Atellica to produce biochemical reagents running on the system. Mr. Wang Weijiang, General Manager of Fosun Long March, and Ms. Guo Yiming, Vice President of China Medical Diagnostic System of China Medical, attended the signing ceremony and jointly unveiled the wonderful prelude of this strategic cooperation.

 

This strategic cooperation with Siemens Medical will realize the system matching of Fosun Long March self-generated chemical reagents and Siemens biochemical instruments. In the future, it will promote the complementary advantages of both parties, market synergy, and work together to bring customers more excellent products for the field of in vitro diagnostics to contribute to its rapid development.

ͼ3.jpg

 


MedicalSystem Biotechnology and Jointown reached a clinical mass spectrometry project cooperation

 

On October 10th , Sun Yanbing, Deputy General Manager of Jointown Medical Device Group; Chen Lei, IVD Product Director; Song Jun, General Manager of Guangdong Jointown, and Yang Hong, General Manager of IVD Division, visited MedicalSystem Biotechnology  to discuss clinical mass spectrometry projects for the cooperation, Zou Jihua, General Manager of MedicalSystem Biotechnology, and Zhang Chao, Sales Director of Mass Spectrometry, gave a warm reception.

 

During the negotiation, the two parties fully affirmed the future development of mass spectrometry technology and conducted in-depth exchanges and discussions on future cooperation. After that, the two parties formally signed a mass spectrometry project cooperation agreement.The layout of this cooperation in South China will give full play to Jointown's advantages in channel layout and services and MedicalSystem Biotechnology's clinical mass spectrometry product development, registration, and production. The two parties will join forces to jointly promote the development and popularization of mass spectrometry technology in China.At the same time, it also laid a good foundation for the national cooperation between MedicalSystem Biotechnology and Jointown in the field of mass spectrometry.

ͼ4.jpg


CAIVD WeChat
Subscription Account
CAIVD WeChat
Channels

China Association of In-vitro Diagnostics

Part of the information in our website is from the internet.

If by any chance it violates your rights, please contact us.